News

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show striking effectiveness across diverse populations at high risk for HIV.
Doctors with special licenses no longer need to use special prescription pads that are difficult to obtain for their patients ...
WHO has officially recommended twice-yearly injectable lenacapavir for HIV prevention, marking a major shift in global HIV ...
From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?
Doctors with special licenses no longer need to use special prescription pads, called yellow prescriptions (Rx) because of ...
For too long, conversations around HIV prevention have been wrapped in shame, confusion, or silence. But that’s starting to change, thanks to platforms like Mistr. As a queer-owned service built with ...
Although Viagra is effective for most guys with erectile dysfunction (ED), it’s important to make sure you’re taking the right dose. Too low of a Viagra dosage and your erections may not be as firm or ...
Ballroom mother Monica Hudson called her "the walking wonder" — a trans woman who could “set fire” to any runway and light up ...
DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
This groundbreaking HIV initiative designed to meet Black and LGBTQ+ communities where they are — spiritually, culturally, ...
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...